153 related articles for article (PubMed ID: 15487766)
21. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial.
Burk RF; Norsworthy BK; Hill KE; Motley AK; Byrne DW
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):804-10. PubMed ID: 16614127
[TBL] [Abstract][Full Text] [Related]
22. No effect of selenium supplementation on serum glucose levels in men with prostate cancer.
Algotar AM; Stratton MS; Stratton SP; Hsu CH; Ahmann FR
Am J Med; 2010 Aug; 123(8):765-8. PubMed ID: 20670733
[TBL] [Abstract][Full Text] [Related]
23. A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats.
Jia X; Li N; Chen J
Life Sci; 2005 Mar; 76(17):1989-2003. PubMed ID: 15707881
[TBL] [Abstract][Full Text] [Related]
24. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
[TBL] [Abstract][Full Text] [Related]
25. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
[TBL] [Abstract][Full Text] [Related]
26. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.
Capodice JL; Gorroochurn P; Cammack AS; Eric G; McKiernan JM; Benson MC; Stone BA; Katz AE
J Soc Integr Oncol; 2009; 7(2):43-51. PubMed ID: 19476738
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
[TBL] [Abstract][Full Text] [Related]
28. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Marshall JR
Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
[TBL] [Abstract][Full Text] [Related]
29. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
30. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
[TBL] [Abstract][Full Text] [Related]
31. Selenium supplementation does not affect testicular selenium status or semen quality in North American men.
Hawkes WC; Alkan Z; Wong K
J Androl; 2009; 30(5):525-33. PubMed ID: 19342701
[TBL] [Abstract][Full Text] [Related]
32. Plasma selenium level before diagnosis and the risk of prostate cancer development.
Brooks JD; Metter EJ; Chan DW; Sokoll LJ; Landis P; Nelson WG; Muller D; Andres R; Carter HB
J Urol; 2001 Dec; 166(6):2034-8. PubMed ID: 11696701
[TBL] [Abstract][Full Text] [Related]
33. DNA stability and serum selenium levels in a high-risk group for prostate cancer.
Karunasinghe N; Ryan J; Tuckey J; Masters J; Jamieson M; Clarke LC; Marshall JR; Ferguson LR
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):391-7. PubMed ID: 15006914
[TBL] [Abstract][Full Text] [Related]
34. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
35. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
[TBL] [Abstract][Full Text] [Related]
36. High-selenium yeast supplementation in free-living North American men: no effect on thyroid hormone metabolism or body composition.
Hawkes WC; Keim NL; Diane Richter B; Gustafson MB; Gale B; Mackey BE; Bonnel EL
J Trace Elem Med Biol; 2008; 22(2):131-42. PubMed ID: 18565425
[TBL] [Abstract][Full Text] [Related]
37. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
Sieja K; Talerczyk M
Gynecol Oncol; 2004 May; 93(2):320-7. PubMed ID: 15099940
[TBL] [Abstract][Full Text] [Related]
38. Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat.
Brown AP; Morrissey RL; Faircloth GT; Levine BS
Cancer Chemother Pharmacol; 2002 Oct; 50(4):333-40. PubMed ID: 12357309
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH
BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858
[TBL] [Abstract][Full Text] [Related]
40. Selenium supplementation of lactating dairy cows: effect on selenium concentration in blood, milk, urine, and feces.
Juniper DT; Phipps RH; Jones AK; Bertin G
J Dairy Sci; 2006 Sep; 89(9):3544-51. PubMed ID: 16899690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
